Cargando…

Biomarkers of Type IV Collagen Turnover Reflect Disease Activity in Patients with Early-Stage Non-Alcoholic Fatty Liver (NAFL)

SIMPLE SUMMARY: The Global increase in obesity and type II diabetes has led to a rapid increase in liver disease caused by fat accumulation in the liver. Therefore, it is of utmost importance to find blood-based markers that may enable the identification of persons with early-stage disease, especial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lønsmann, Ida, Grove, Jane I., Haider, Asma, Kaye, Philip, Karsdal, Morten A., Leeming, Diana J., Aithal, Guruprasad P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451710/ https://www.ncbi.nlm.nih.gov/pubmed/37626973 http://dx.doi.org/10.3390/biology12081087

Ejemplares similares

A systems biology approach to study non-alcoholic fatty liver (NAFL) in women with obesity
por: Meijnikman, Abraham S., et al.
Publicado: (2022)

The food contaminant deoxynivalenol provokes metabolic impairments resulting in non-alcoholic fatty liver (NAFL) in mice
por: Barbouche, Rym, et al.
Publicado: (2020)

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
por: Xu, Xiaohan, et al.
Publicado: (2022)

Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
por: Lewinska, Monika, et al.
Publicado: (2021)

Association of Systemic Collagen Type IV Formation with Survival among Patients Undergoing Hemodialysis
por: Leeming, Diana J., et al.
Publicado: (2013)

Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor
por: Hansen, Niels Ulrik Brandt, et al.
Publicado: (2016)

Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort
por: Tricò, Domenico, et al.
Publicado: (2018)

Association of Versican Turnover with All-Cause Mortality in Patients on Haemodialysis
por: Genovese, Federica, et al.
Publicado: (2014)

Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis
por: Jessen, H., et al.
Publicado: (2021)

Cartilage Turnover Reflected by Metabolic Processing of Type II Collagen: A Novel Marker of Anabolic Function in Chondrocytes
por: Gudmann, Natasja Stæhr, et al.
Publicado: (2014)

Collagen turnover profiles in chronic kidney disease
por: Rasmussen, Daniel Guldager Kring, et al.
Publicado: (2019)

MMP Mediated Degradation of Type IV Collagen Alpha 1 and Alpha 3 Chains Reflects Basement Membrane Remodeling in Experimental and Clinical Fibrosis – Validation of Two Novel Biomarker Assays
por: Sand, Jannie Marie, et al.
Publicado: (2013)

Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
por: Chalmers, Jane, et al.
Publicado: (2019)

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)
por: Murphy, William A., et al.
Publicado: (2022)

Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients
por: Kehlet, S. N., et al.
Publicado: (2016)

Biomarkers of collagen turnover are related to annual change in FEV(1) in patients with chronic obstructive pulmonary disease within the ECLIPSE study
por: Leeming, Diana J., et al.
Publicado: (2017)

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
por: Boyle, Marie, et al.
Publicado: (2019)

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis
por: Jessen, Henrik, et al.
Publicado: (2021)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Metabolic Imaging in Non-Alcoholic Fatty Liver Disease: Applications of Magnetic Resonance Spectroscopy
por: Thiagarajan, Prarthana, et al.
Publicado: (2021)

Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis
por: Veidal, Sanne S, et al.
Publicado: (2011)

Collagen Type III and VI Turnover in Response to Long-Term Immobilization
por: Sun, Shu, et al.
Publicado: (2015)

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis
por: Hesse, Christina, et al.
Publicado: (2022)

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation
por: Thiele, Maja, et al.
Publicado: (2021)

Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD
por: Bihlet, Asger Reinstrup, et al.
Publicado: (2017)

Non-invasive quantification of collagen turnover in renal transplant recipients
por: Stribos, Elisabeth G. D., et al.
Publicado: (2017)

Matrix Metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis
por: Siebuhr, Anne Sofie, et al.
Publicado: (2012)

Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study
por: Juhl, Pernille, et al.
Publicado: (2018)

Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis
por: Erhardtsen, Elisabeth, et al.
Publicado: (2021)

Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients
por: Nielsen, Mette Juul, et al.
Publicado: (2019)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)

Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation
por: Al-Awadi, Amina, et al.
Publicado: (2021)

Accelerated extracellular matrix turnover during exacerbations of COPD
por: Sand, Jannie M. B., et al.
Publicado: (2015)

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV
por: Dold, Leona, et al.
Publicado: (2023)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Age-related collagen turnover of the interstitial matrix and basement membrane: Implications of age- and sex-dependent remodeling of the extracellular matrix
por: Kehlet, Stephanie N., et al.
Publicado: (2018)

Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism?
por: Hansen, Christian S., et al.
Publicado: (2023)

Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease
por: Vesterhus, Mette, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tjpvnq1aor4per9dd1nju7s2s7